| Literature DB >> 16919159 |
Cynthia Fraser1, Alison Murray, Jennifer Burr.
Abstract
BACKGROUND: Health technology assessments of surgical interventions frequently require the inclusion of non-randomised evidence. Literature search strategies employed to identify this evidence often exclude a methodological component because of uncertainty surrounding the use of appropriate search terms. This can result in the retrieval of a large number of irrelevant records. Methodological filters would help to minimise this, making literature searching more efficient.Entities:
Mesh:
Year: 2006 PMID: 16919159 PMCID: PMC1569861 DOI: 10.1186/1471-2288-6-41
Source DB: PubMed Journal: BMC Med Res Methodol ISSN: 1471-2288 Impact factor: 4.615
Definitions of Sensitivity, Precision and Specificity
| Manual review of subject only electronic search | |||
| Non-randomised studies (Reference standard) | Other studies (Non-reference standard) | ||
| Search filter | Retrieved | A | B |
| Not retrieved | C | D | |
Sensitivity = A/(A+C) × 100
Precision = A/(A+B) × 100
Specificity = D/(B+D) × 100
Composition of Reference Standard
| Study design | Total | MEDLINE | EMBASE | |||
| N | % | N | % | N | % | |
| Comparative – prospective | 19 | (8.7) | 18 | (8.7) | 16 | (8.4) |
| Comparative – retrospective | 16 | (7.4) | 14 | (6.8) | 13 | (6.8) |
| Case series – prospective | 104 | (47.9) | 99 | (48.1) | 93 | (48.7) |
| Case series – retrospective | 70 | (32.3) | 67 | (32.5) | 61 | (31.9) |
| Case series – unclear | 8 | (3.7) | 8 | (3.9) | 8 | (4.2) |
| TOTAL | 217 | (100.0) | 206 | (100.0) | 191 | (100.0) |
Candidate search terms for MEDLINE
| Search Term | Reference Standard retrieved (N = 206) | Total retrieved (N = 1564) | Sensitivity | Precision | Specificity |
| Case-control studies/ | 2 | 8 | 1.0 | 25.0 | 99.5 |
| Cohort studies/ | 5 | 16 | 2.4 | 31.2 | 99.2 |
| Comparative studies/ | 106 | 326 | 51.5 | 32.5 | 83.8 |
| Follow-up studies/ | 35 | 135 | 17.0 | 25.9 | 92.6 |
| Prospective studies/ | 68 | 240 | 33.0 | 28.3 | 87.3 |
| Retrospective studies/ | 78 | 282 | 37.9 | 27.7 | 85.0 |
| Time factors/ | 15 | 60 | 7.3 | 25.0 | 96.7 |
| Treatment outcome/ | 75 | 323 | 36.4 | 23.2 | 81.7 |
| Case reports.pt | 5 | 393 | 2.4 | 1.3 | 71.4 |
| Clinical trial.pt | 25 | 139 | 12.1 | 18.0 | 91.6 |
| Evaluation studies.pt | 12 | 44 | 5.8 | 27.3 | 97.6 |
| baseline | 16 | 49 | 7.8 | 32.6 | 97.6 |
| case control$ | 3 | 10 | 1.5 | 30.0 | 99.5 |
| case series | 28 | 132 | 13.6 | 21.2 | 92.3 |
| cases | 40 | 223 | 19.4 | 17.9 | 86.5 |
| chang$ | 56 | 310 | 27.2 | 18.1 | 81.3 |
| cohort | 10 | 24 | 4.8 | 41.7 | 99.0 |
| compare$ or compara$ | 98 | 312 | 47.6 | 31.4 | 84.2 |
| consecutive$ | 56 | 163 | 27.2 | 34.4 | 92.1 |
| evaluat$ | 100 | 499 | 48.5 | 20.0 | 70.6 |
| follow$ | 59 | 272 | 28.6 | 21.7 | 84.3 |
| non compara$ or noncompara$ | 14 | 83 | 6.8 | 16.9 | 94.9 |
| non random$ or nonrandom$ | 19 | 51 | 9.2 | 37.2 | 97.6 |
| observational | 3 | 22 | 1.5 | 13.6 | 98.6 |
| post operat$ or postoperat$ | 105 | 538 | 51.0 | 19.5 | 68.1 |
| pre operat$ or preoperat$ | 110 | 454 | 53.4 | 24.2 | 74.7 |
| prospective$ | 60 | 216 | 29.1 | 27.8 | 88.5 |
| retrospective$ | 66 | 242 | 32.0 | 27.3 | 87.0 |
| reviewed | 19 | 67 | 9.2 | 28.4 | 96.5 |
| case control | 4 | 12 | 1.9 | 33.3 | 99.4 |
| cohort | 11 | 29 | 5.3 | 37.9 | 98.7 |
| compare$ or compara$ | 135 | 464 | 65.5 | 29.1 | 75.8 |
| follow$ | 68 | 312 | 33.0 | 21.8 | 82.0 |
| prospective$ | 69 | 260 | 33.5 | 26.5 | 85.9 |
| retrospective$ | 79 | 296 | 38.3 | 26.7 | 84.0 |
| postoperat$ or post operat$ | 130 | 752 | 63.1 | 17.3 | 54.2 |
| preoperat$ or pre operat$ | 112 | 466 | 54.4 | 24.0 | 73.9 |
Key
/ MeSH term
pt Term from publication type field
tw Text word(s) from title and/or abstract fields
mp Term from MeSH and/or title and/or abstract fields.
$ Truncation symbol
Candidate search terms for EMBASE
| Search Term | Reference Standard retrieved (N = 191) | Total retrieved (N = 1521) | Sensitivity | Precision | Specificity |
| Case report/ | 1 | 348 | 0.5 | 0.3 | 73.9 |
| Clinical trial/ | 23 | 131 | 12.0 | 17.6 | 91.9 |
| Cohort analysis/ | 3 | 9 | 1.6 | 33.3 | 99.5 |
| Comparative study/ | 13 | 39 | 6.8 | 33.3 | 98.0 |
| Controlled study/ | 79 | 309 | 41.4 | 25.6 | 82.7 |
| Follow-up study/ | 45 | 212 | 23.6 | 21.2 | 87.4 |
| Major clinical study/ | 106 | 308 | 55.5 | 34.4 | 84.8 |
| Prospective study/ | 22 | 74 | 11.5 | 29.7 | 96.1 |
| Retrospective study/ | 29 | 108 | 15.2 | 26.8 | 94.1 |
| Treatment outcome/ | 88 | 447 | 46.1 | 19.7 | 73.0 |
| baseline | 16 | 47 | 8.4 | 34.0 | 97.7 |
| case control$ | 3 | 9 | 1.6 | 33.3 | 99.5 |
| case series | 27 | 122 | 14.1 | 22.1 | 92.9 |
| cases | 38 | 201 | 19.9 | 18.9 | 87.7 |
| chang$ | 51 | 297 | 26.7 | 17.2 | 81.5 |
| cohort | 8 | 19 | 4.2 | 42.1 | 99.2 |
| compar$ or compara$ | 90 | 287 | 47.1 | 31.4 | 85.2 |
| consecutive$ | 51 | 142 | 26.7 | 35.9 | 93.2 |
| evaluat$ | 96 | 425 | 50.3 | 22.6 | 75.3 |
| follow$ | 50 | 259 | 26.2 | 19.3 | 84.3 |
| non compara$ or noncompara$ | 13 | 78 | 6.8 | 16.7 | 95.1 |
| non random$ or nonrandom$ | 19 | 46 | 9.9 | 41.3 | 98.0 |
| observational | 3 | 20 | 1.6 | 15.0 | 98.7 |
| postoperat$ or post operat$ | 91 | 494 | 47.6 | 18.4 | 69.7 |
| preoperat$ or pre operat$ | 101 | 418 | 52.9 | 24.2 | 76.2 |
| prospective$ | 56 | 195 | 29.3 | 28.7 | 89.5 |
| retrospective$ | 61 | 223 | 31.9 | 27.3 | 87.8 |
| reviewed | 20 | 66 | 10.5 | 30.3 | 96.5 |
| cohort$ | 8 | 21 | 4.2 | 38.1 | 99.0 |
| compare$ or compara$ | 90 | 297 | 47.1 | 30.3 | 84.4 |
| follow$ | 61 | 325 | 31.9 | 18.8 | 80.1 |
| prospective$ | 57 | 200 | 29.8 | 28.5 | 89.2 |
| retrospective$ | 64 | 233 | 33.5 | 27.5 | 87.3 |
| postoperat$ or post operat$ | 123 | 827 | 64.4 | 14.9 | 47.1 |
| preoperat$ or pre operat$ | 106 | 491 | 55.5 | 21.6 | 71.1 |
Key
/ EMTREE term
tw Text word(s) from title and/or abstract fields
mp Term from EMTREE and/or title and/or abstract fields.
$ Truncation symbol
Retained candidate terms
| Comparative studies/ | Comparative studies/ | Controlled study/ | Controlled study/ |
| (preoperat$ or pre operat$).mp | (preoperat$ or pre operat$).mp | (preoperat$ or pre operat$).mp | |
| chang$.tw | chang$.tw | chang$.tw | chang$.tw |
| evaluat$.tw | evaluat$.tw | evaluat$.tw | evaluat$.tw |
| reviewed.tw | reviewed.tw | reviewed.tw | reviewed.tw |
| prospective$.tw | prospective$.tw | ||
| retrospective$.tw | retrospective$.tw | ||
| baseline.tw | baseline.tw | baseline.tw | |
| cohort.tw | cohort.tw | ||
| consecutive$.tw | |||
| (compare$ or compara$).tw | (compare$ or compara$).tw | (compare$ or compara$).tw | |
| case series.tw | |||
Performance of MEDLINE and EMBASE Filters
| Filter | Retrieved | Sensitivity % (95% CI) | Precision % (95%CI) | Specificity % (95% CI) | ||
| Reference Standard | Total | % Reduction | ||||
| No filter | 206 | 1564 | - | 100.0 | 13.2 (11.5–14.9) | |
| Precision | 205 | 979 | 37.4 | 99.5 (98.5–100.) | 20.9 (18.4–23.4) | 42.9 (40.3–45.5) |
| Specificity | 205 | 972 | 37.9 | 99.5 (98.5–100.) | 21.1 (18.5–23.7) | 43.5 (40.4–46.6) |
| No filter | 191 | 1521 | - | 100.0 | 12.6 (10.9–14.3) | |
| Precision | 191 | 1065 | 30.0 | 100.0 | 17.9 (15.6–20.2) | 35.3 (32.7–37.9) |
| Specificity | 191 | 1016 | 33.2 | 100.0 | 18.8 (16.4–21.2) | 38.0 (35.1–39.8) |
| No filter | 217 | 1959 | - | 100.0 | 11.1 (9.7–12.5) | |
| Precision | 217 | 1298 | 33.8 | 100.0 | 16.7 (14.7–18.7) | 37.9 (35.3–40.5) |
| Specificity | 217 | 1266 | 35.4 | 100.0 | 17.1 (15.0–19.2) | 39.8 (37.1–42.5) |
Performance of Specificity Filters against Validation Sets.
| MEDLINE | EMBASE | MEDLINE/EMBASE Deduplicated | ||||
| No filter | Filter | No filter | Filter | No filter | Filter | |
| Reference Standard | 39 | 39 | 33 | 32 | 39 | 39 |
| Total retrieved | 682 | 452 | 503 | 393 | 792 | 567 |
| Reference standard retrieved (%) | 100.0 | 97.0 | 100.0 | |||
| Reduction in retrievals (%) | 33.7 | 21.9 | 28.4 | |||
| Reference Standard | 27 | 23 | 27 | 26 | 30 | 30 |
| Total retrieved | 1466 | 886 | 1213 | 852 | 1712 | 1196 |
| Reference standard retrieved (%) | 85.2 | 96.3 | 100.0 | |||
| Reduction in retrievals (%) | 39.6 | 29.8 | 30.1 | |||